You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
完美醫療(01830.HK)逆市續漲11%再破頂 引進全港首部植髮機械人
阿思達克 07-06 10:12
完美醫療(01830.HK)引入全港首部第7代「ARTAS iXTM」植髮機械人。該股今早逆市升破上周所創上市高位10元,最高見10.74元,現造10.62元,續升11%,成交已有888萬股。

完美醫療公布,為配合「生發醫療」業務高速拓展,集團從著名美國醫療儀器生產商引入全港首部第7代「ARTAS iXTM」植發機械人。「ARTAS iXTM」是全球唯一使用機械人的植髮系統,並獲得美國食物藥品管理局的認證,可有效地治療脫髮問題,為客戶提供「不需逢針線」及「精確及可靠的植髮效果」的脫髮治療選擇。

此外,集團主席、行政總裁兼執行董事歐陽江在上周五(2日)於公開市場以平均價每股股份8.9元購買合共130萬股股份,總代價約為1,157萬元,其持股增至71.97%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account